Autonomix Medical AMIX

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.16 (+6.40%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Autonomix Medical (AMIX)
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $2.65

  • Market Cap

    $6.53 Million

  • Price-Earnings Ratio

    0.82

  • Total Outstanding Shares

    2.46 Million Shares

  • Total Employees

    8

  • Dividend

    No dividend

  • IPO Date

    January 29, 2024

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    21 waterway avenue, suite 300, The woodlands, TX, 77380

  • Homepage

    https://www.autonomix.com

Historical Stock Splits

If you bought 20 shares of AMIX before October 25, 2024, you'd have 1 share today.
Execution DateSplit Amount
October 25, 20241-for-20 (Reverse Split)

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Financing Activities$18.65 Million
Net Cash Flow From Investing Activities, Continuing$-13,000
Net Cash Flow From Financing Activities, Continuing$18.65 Million
Net Cash Flow From Operating Activities$-8.04 Million
Net Cash Flow From Investing Activities$-13,000
Net Cash Flow From Operating Activities, Continuing$-8.04 Million

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Income/Loss From Continuing Operations Before Tax$-13.63 Million
Net Income/Loss Attributable To Parent$-13.63 Million
Preferred Stock Dividends And Other Adjustments$0
Other Operating Expenses$6.88 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Net Income/Loss$-13.63 Million

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-13.63 Million
Other Comprehensive Income/Loss$0
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$-13.63 Million

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Fixed Assets$20,000
Assets$11.95 Million
Other Current Liabilities$2.01 Million
Liabilities$2.25 Million
Equity Attributable To Noncontrolling Interest$0
Equity Attributable To Parent$9.71 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about AMIX from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.